𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phlorofucofuroeckol A inhibits the LPS-stimulated iNOS and COX-2 expressions in macrophages via inhibition of NF-κB, Akt, and p38 MAPK

✍ Scribed by A.-Reum Kim; Min-Sup Lee; Tai-Sun Shin; Hong Hua; Byeong-Churl Jang; Jae-Sue Choi; Dae-Seok Byun; Tadanobu Utsuki; Donald Ingram; Hyeung-Rak Kim


Book ID
116920527
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
627 KB
Volume
25
Category
Article
ISSN
0887-2333

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Glucosamine inhibits LPS-induced COX-2 a
✍ Mohamed M. Rafi; Prem N. Yadav; Andrea O. Rossi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 774 KB

## Abstract Glucosamine supplements are very promising nonsteroidal anti‐inflammatory agents widely used for the treatment of arthritis in animals and humans. In this study, we have proposed the molecular mechanism underlying the anti‐inflammatory properties of glucosamine hydrochloride (GLN) using

Roxatidine suppresses inflammatory respo
✍ Eu-Jin Cho; Hyo-Jin An; Ji-Sun Shin; Hye-Eun Choi; Jane Ko; Young-Wuk Cho; Hyung 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 638 KB

Roxatidine is a novel, specific, competitive H 2 -receptor antagonist that is used to treat gastric and duodenal ulcers, and which is known to suppress the growth of several tumors by reducing vascular endothelial growth factor (VEGF) expression. Nevertheless, it remains unclear whether roxatidine h